Edges in Network
Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
Node | HLA-DOA |
Upstream (Parents) |
---|
(<<) ACTN3 → HLA-DOA |
(<<) ADAM12 → HLA-DOA |
(<<) COIL → HLA-DOA |
(<<) CRCT1 → HLA-DOA |
(<<) IL1R2 → HLA-DOA |
(<<) PDGFB → HLA-DOA |
(<<) PIP4K2A → HLA-DOA |
(<<) PITPNA → HLA-DOA |
(<<) PRKCB → HLA-DOA |
(<<) PRSS3 → HLA-DOA |
(<<) PTGER1 → HLA-DOA |
(<<) SHC1 → HLA-DOA |
(<<) SOCS3 → HLA-DOA |
(<<) SPRR1B → HLA-DOA |
Downstream (Children) |
---|
HLA-DOA → BPGM (>>) |
HLA-DOA → CEBPE (>>) |
HLA-DOA → DRD4 (>>) |
HLA-DOA → IL1F9 (>>) |
HLA-DOA → IL1RN (>>) |
HLA-DOA → KLK7 (>>) |
HLA-DOA → MMP17 (>>) |
HLA-DOA → PDK2 (>>) |
HLA-DOA → RPA4 (>>) |